Skip to main content Skip to page footer

Endometrial cancer

Logo des NCT Heidelberg Logo des NCT Heidelberg

Endometrial cancer

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Metastatic Disease: First-Line-Therapy

There are currently no studies available

Metastatic Disease: Follow-Up Treatment

Title: A Phase I/II First-In-Human Clinical Trial to Evaluate the Safety, Tolerability and Anti-Tumor Activity of IMA402, a Bispecific TCER® Targeting PRAME, in Patients With Recurrent and/or Refractory Solid Tumors
Phase: I/II
Contact: Angela Diana Klein / Kontaktperson
Email-Address: AngelaDiana.Klein(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Jessica Hassel
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05958121
EU CTIS/EudraCT: Die Studie ist im EU-CTIS registriert. CTIS: 2022-503133-54-00

Title: Phase 1 Study Evaluating Genetically Modified Autologous T Cells Expressing a TCR Recognizing a Cancer/Germline Antigen as Monotherapy or in Combination With Nivolumab in Patients With Recurrent and/or Refractory Solid Tumors.
Phase: I
Contact: Monika Pipa / Kontaktperson
Email-Address: Monika.Pipa(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Dirk Jäger
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03686124
EU CTIS/EudraCT: Siehe EU klinisches Studienregister EudraCT: 2019-002370-31

Title: A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients With Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase: I/II
Contact: Elisabeth Lawrence / Kontaktperson
Email-Address: Elisabeth.Lawrence(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Georg Martin Haag
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04585750
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: A Phase I Study to Evaluate Safety and Early Signs of Efficacy of the Human Monoclonal Antibody-cytokine Fusion Protein IL12-L19L19.
Phase: I
Contact: Angela Diana Klein / Kontaktperson
Email-Address: AngelaDiana.Klein(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Jessica Hassel
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT04471987
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

Title: IMPULS-A: Implementierung eines Unterstützungsprogramms für Langzeitkrebsüberlebende im Alter
Phase: N/A
Contact: M. Sc. Charlotte Flock / Kontaktperson
Email-Address: IMPULS-A(at)med.uni-heidelberg.de
Clinical Investigator: Prof. Dr. med. Hans-Christoph Friederich
Registration: Keine Registernummer angegeben.
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: Randomized Comparison of Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in Patients With Advanced Rare Cancers (RATIONALE)
Phase: N/A
Contact: Elke Bauriegel / Kontaktperson
Email-Address: rationale_pm(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Richard Schlenk
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT06855134
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A:

Title: NCT MASTER Plattform Molecularly Aided Stratification for Tumor Eradication Research
Phase: N/A
Contact: MASTER Studienbüro / Kontaktperson
Email-Address: master(at)nct-heidelberg.de
Clinical Investigator: Prof. Dr. med. Stefan Fröhling
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05852522
EU CTIS/EudraCT: Keine Registernummer angegeben. N/A: